• Mar. Mag 21st, 2024

masld

  • Home
  • Semaglutide Reduces Severity of Common Liver Disease in People with HIV #CROI2024

Semaglutide Reduces Severity of Common Liver Disease in People with HIV #CROI2024

A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according…